In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 8th, 2004 | 25 | No |
Popular Name: Oxyphenonium bromide Oxyphenonium bromide
2-((Cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methylethanaminium
2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium
2-[2-cyclohexyl(hydroxy)phenylacetoxy]-n,n-diethyl-n-methylethanaminium
50-10-2; Antrenyl (TN); D06877; Oxyphenonium bromide (INN)
CPD000058660; OXYPHENONIUM BROMIDE
CPD000058660; OXYPHENONIUM BROMIDE; SAM001246887
Ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methyl-
[2-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-ethyl]-diethyl-methyl-ammonium
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.29 | 11.8 | -32.3 | 1 | 4 | 1 | 47 | 348.507 | 9 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.36e-04 g/l | DrugBank-approved |
Therapy | anticholinergic, anticonvulsant | SMDC Pharmakon |
PUBCHEM_PATENT_ID | EP0035903A1; EP0063870A2; EP0126684A2; EP0126684B1; EP0169105A2; EP0169105B1; EP0208617A1; EP0227494A1; EP0227494B1; EP0302693A2; EP0302693B1; EP0314206A1; EP0314206B1; EP0336543A1; EP0354186A1; EP0354186B1; EP0424043A1; EP0424043B1; EP0437368B1; EP044710 | IBM Patent Data |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : O5501; 1 bromide | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: O5501; SALT: 1 bromide | NIH Clinical Collection via PubChem |